Evidence map›Paper›PMID 31511863›Full record

SynthesisThe Journal of clinical endocrinology and metabolism2020

Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis.

Friso de Vries, Mees Bruin, Daniel J Lobatto, Olaf M Dekkers, Jan W Schoones, Wouter R van Furth, Alberto M Pereira, Niki Karavitaki, Nienke R Biermasz, Amir H Zamanipoor Najafabadi

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. The interplay of circadian rhythms and cancer pain: a narrative review.Journal of anesthesia, analgesia and critical care · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Clinical pharmacology of opioid analgesics].Schmerz (Berlin, Germany) · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Friso de VriesDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Mees BruinDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Daniel J LobattoDepartment of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands.
Olaf M DekkersDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Jan W SchoonesWalaeus Library, Leiden University Medical Center, Leiden, The Netherlands.
Wouter R van FurthDepartment of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands.
Alberto M PereiraDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Niki KaravitakiInstitute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Nienke R BiermaszDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Amir H Zamanipoor NajafabadiCentre for Endocrine Tumors Leiden (CETL), Leiden University Medical Center, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe increased use of opioids has resulted in an unprecedented opioid epidemic. Chronic opioid use causes hypogonadism, but its frequency, as well as the effects of opioids on other hypothalamo-pituitary-end organ hormone axes, remains unclear.

objectiveThe aim of this systematic review and meta-analysis was to assess the effects of opioid use on pituitary function.

methodsEight electronic databases were searched for articles published up to May 8, 2018. Fixed or random effects meta-analysis was performed to estimate pooled proportions with 95% confidence intervals (CI). This study is reported following the PRISMA and MOOSE guidelines. DATA SYNTHESIS: 52 studies (22 low risk of bias) were included describing 18 428 subjects, consisting of patients with chronic pain (n = 21 studies) or on maintenance treatment for opioid addiction (n = 9) and healthy volunteers (n = 4). The most frequently used opioid was methadone (n = 13 studies), followed by morphine (n = 12). Prevalence of hypogonadism was 63% (95% CI: 55%-70%, 15 studies, 3250 patients, 99.5% males). Prevalence of hypocortisolism relying on dynamic and nondynamic testing was 15% (95% CI: 6%-28%, 5 studies, 205 patients, 57.5% males) and including only studies using the insulin tolerance tests 24% (95% CI 16%-33%, 2 studies, n = 97 patients). In 5 out of 7 studies, hyperprolactinemia was present. No clear effects on the somatotropic and hypothalamo-pituitary-thyroid axes were described.

conclusionsHypogonadism occurs in more than half of male opioid users, and hypocortisolism in approximately one-fifth of all patients. Periodical evaluation of at least the gonadal and adrenal axes is therefore advisable.

Indexed as

Analgesics, OpioidChronic PainEndocrine System DiseasesHumansHypogonadismPituitary HormonesPrognosisAnalgesics, OpioidPituitary Hormonesanalgesicshypocortisolismhypogonadismopioidspituitary

Identifiers

PMID31511863
PMCPMC7054712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.